APP2018 organising lead Kos Sclavos has issued an alert around spam emails offering attendee lists for APP2018.
Sclavos emphasised that the emails are in no way associated with APP or the Guild, which "do not sell or provide contact details to any third parties, ever."
PEOPLE with obesity who take glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a reduced risk of cancer compared to those not using those medications, according to US research published today in JAMA Oncology.
PHARMACISTS from across Australia recently came together for the Pharmacy Snow Business Conference at Mt Buller, sharing a passion for skiing alongside their commitment to professional development.
PHARMX Technologies yesterday announced strong results for the financial year ending 30 Jun 2025, with total revenues of $7.5 million, up 13% on the previous corresponding period.
Notifications
